Received government funding or funding expected in current financial year
No
Business Relationships
ors/Biotechnologies Aramis is not a subsidiary of any other parent companies.
Beneficiaries of the Lobbying Activity
ors/Biotechnologies Aramis does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
What is being lobbied?
Subject Matters
Research and Development
Subject Matter Details
Grant, Contribution or Other Financial Benefit
Contribution financière du Fonds stratégique pour l’innovation (FIS) pour aider au développement d'une capacité de bioproduction de vaccins dans les plantes au Canada.
Who is being lobbied?
Government Institutions
Innovation, Science and Economic Development Canada (ISED)
Communication techniques
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Oral communication
Written communication
Who are the lobbyists?
Senior Officers whose lobbying activities represent less than 20% of their Duties
Marc-Andre D'Aoust,
CSO
|
No public offices held
Nicolas Petit,
COO
|
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
ors / Biotechnologies Aramis - Address & business activities
Address:
2552 boulevard du parc technologique
quebec, QC G1p 4s6
Canada
Telephone number:
418-575-7789
Description of activities:
Aramis Biotechnologies est une entreprise canadienne fondée en 2023 et basée à Québec qui se spécialise dans la production de vaccins innovants dans les plantes.
Public offices held:
Marc-Andre D'Aoust
Government funding
No government funding was received during the last completed financial year.